The global Retinal Disorders Treatment Market, valued at US$ 9.18 billion in 2022, is projected to reach US$ 19 billion by 2030, growing at a compound annual growth rate (CAGR) of 7% during the forecast period. Retinal disorders, such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion, are treated with anti-VEGF therapies, laser treatments, and emerging...